MedPath

Effect of Cola on Urinary Stone Risk Factors

Not Applicable
Completed
Conditions
Kidney Stone
Interventions
Drug: Cola beverage
Registration Number
NCT00289120
Lead Sponsor
Emory University
Brief Summary

Examine the effects of cola on risks of kidney stones

Detailed Description

Prospective crossover study examining the risks of cola on stone risk factors.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
13
Inclusion Criteria
  • urolithiasis, healthy volunteer
Exclusion Criteria

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
Deionized waterDeionized waterSubjects will be given 500cc of deionized water.
Cola beverageCola beverageSubjects will be given 500cc of Cola twice daily.
Primary Outcome Measures
NameTimeMethod
The Plasma and Urine Parametersat the end of 6-day intervention of Cola and water phase

The Urine Parameters that were assessed at the end of cola and water (arms) phase:

Urine Parameters:

uNa (mEq per d) uK (mEq per d)

The parameters were consolidated into the one value as a mean of all the values in the phase or group (Table 3) and later for longitudinal analysis as a mean of all the values in the phase for each participant (Table 4).

measure of dispersion was standard deviation.

The Plasma Osmolarityat the end of 6-day intervention of cola and water phase

The Plasma osmolarity that were assessed at the end of cola and water (arms) phase:

Plasma Parameters:

OSM (mOsm/L)

The parameters were consolidated into the one value as a mean of all the values in the phase or group (Table 3) and later for longitudinal analysis as a mean of all the values in the phase for each participant (Table 4).

measure of dispersion was standard deviation.

Secondary Outcome Measures
NameTimeMethod
Urinary pHat the end of each 6-day intervention in Cola and Water Phase

The Urine pH that were assessed at the end of cola and water (arms) phase The parameters were consolidated into the one value as a mean of all the values in the phase or group (Table 3) and later for longitudinal analysis as a mean of all the values in the phase for each participant (Table 4).

measure of dispersion was standard deviation.

Total Urine Volumeat the end of each 6-day intervention in Cola and Water Phase

The Plasma and Urine Parameters that were assessed at the end of cola and water (arms) phase:

Urine Parameters:

Total Urine Volume (mL/day)

The parameters were consolidated into the one value as a mean of all the values in the phase or group (Table 3) and later for longitudinal analysis as a mean of all the values in the phase for each participant (Table 4).

measure of dispersion was standard deviation.

Trial Locations

Locations (1)

Emory University

🇺🇸

Atlanta, Georgia, United States

© Copyright 2025. All Rights Reserved by MedPath